Tyrosine positron emission tomography and protein synthesis rate in pituitary adenoma: different effects of surgery and radiation therapy.

[1]  B. Wolffenbuttel,et al.  Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. , 2007, International journal of radiation oncology, biology, physics.

[2]  C. Muhr.  Positron Emission Tomography in Acromegaly and Other Pituitary Adenoma Patients , 2006, Neuroendocrinology.

[3]  S. Goldman,et al.  11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  M. Mullins,et al.  Postoperative Imaging of the Pituitary Gland , 2005, Topics in magnetic resonance imaging : TMRI.

[5]  N. Gittoes.  Radiotherapy for Non-Functioning Pituitary Tumors—When and Under What Circumstances? , 2003, Pituitary.

[6]  R. Dullaart,et al.  Evaluation of adrenal function in patients with hypothalamic and pituitary disorders: comparison of serum cortisol, urinary free cortisol and the human‐corticotrophin releasing hormone test with the insulin tolerance test , 1999, Clinical endocrinology.

[7]  J. Pruim,et al.  11C-tyrosine position emission tomography and 1H magnetic resonance spectroscopy of the response of brain gliomas to radiotherapy , 1998, Neuroradiology.

[8]  I. Pomposo,et al.  Postoperative follow-up of pituitary adenomas after trans-sphenoidal resection: MRI and clinical correlation , 1996, Neuroradiology.

[9]  A. Willemsen,et al.  In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  M. Bergström,et al.  Differentiation of pituitary adenoma and meningioma: visualization with positron emission tomography and [11C]-L-deprenyl. , 1992, Neurosurgery.

[11]  W. Vaalburg,et al.  Radiation-induced inhibition of tumor growth as monitored by PET using L-[1-11C]tyrosine and fluorine-18-fluorodeoxyglucose. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  C. Crouzel,et al.  Amino acids for the measurement of protein synthesis in vivo by PET. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[13]  M. Bergström,et al.  PET as a tool in the clinical evaluation of pituitary adenomas. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  K. Ishiwata,et al.  Metabolic studies with L-[1-14C]tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  W. Vaalburg,et al.  PET studies with l-[1-11C]tyrosine, l-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment , 2004, European Journal of Nuclear Medicine.